Workflow
IP Strategy Announces Reverse Stock Split
Globenewswire· 2025-10-31 20:30
GIG HARBOR, Wash., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Heritage Distilling Holding Company Inc. d/b/a IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock. The reverse stock split is expected to become effective at 12:01 a.m. on November 5, 2025, and the Company’s common stock is expected to begin trading on the Nasdaq Capi ...
Lennar Announces Extension of Expiration Date of Exchange Offer
Prnewswire· 2025-10-31 20:30
Core Points - Lennar Corporation is extending the expiration date for its Exchange Offer for Millrose Properties shares due to the ongoing U.S. federal government shutdown [1][2] - The new expiration date for the Exchange Offer is now set for November 14, 2025, instead of the previously scheduled November 7, 2025 [1][2] - The Exchange Offer cannot be completed until the SEC declares the Registration Statement effective, which is currently delayed due to the government shutdown [2][3] Company Information - Lennar Corporation, founded in 1954, is a leading builder of quality homes across various segments, including affordable and active adult homes [5] - The company also provides mortgage financing and title services through its Financial Services segment and develops multifamily rental properties [5] Exchange Offer Details - If the SEC does not declare the Registration Statement effective by the new expiration date, Lennar may further extend the Exchange Offer or terminate it without accepting any shares [3][4] - All other terms and conditions of the Exchange Offer will remain unchanged, and Lennar reserves the right to amend or withdraw the offer at any time [4]
Unitil Completes Purchase of Maine Natural Gas Company
Globenewswire· 2025-10-31 20:30
HAMPTON, N.H., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE:UTL) (unitil.com) today announced that it completed the purchase of Maine Natural Gas Company (“Maine Natural”) from Avangrid Enterprises, Inc. The Stock Purchase Agreement (the “Agreement”) between Avangrid Enterprises, Inc. and Unitil was first announced on April 1, 2025. All conditions of the Agreement, including the receipt of approvals from the Maine Public Utilities Commission, were materially completed as of the closing date. M ...
Springview Holdings Ltd Initiates Appeal Following Nasdaq Delisting Notice
Globenewswire· 2025-10-31 20:30
Singapore, Oct. 31, 2025 (GLOBE NEWSWIRE) -- As previously reported, on April 25, 2025, Springview Holdings Ltd (Nasdaq: SPHL) (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) regarding the Company’s failure to comply with Nasdaq Continued Listing Rule 5550(a)(2) (the “Rule”), which requires listed securities to maintain a minimum bid price of $1.00 per share. A failure to comply with Rule 5550(a)(2) exists when listed securities fail to mai ...
Mobile-health Network Solutions Reports FY2025 Results and Operational Update
Newsfile· 2025-10-31 20:30
Singapore, Singapore--(Newsfile Corp. - October 31, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced its financial results for the fiscal year ended June 30, 2025 ("FY2025"), and outlined its strategy to scale its proprietary AI-driven virtual-care platform across high-growth emerging markets.During FY2025, the Company completed its transition from an asset-heavy structure to an asset-light virtual-care platform, significant ...
Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November
Globenewswire· 2025-10-31 20:30
TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in November as follows: UBS Global Healthcare ConferenceMonday, November 10, 2025, at 8:45 A.M. Eastern Time (ET) Jefferies London Healthcare ConferenceTuesday, November 18, 2025, at 11:00 A.M. Greenwich Mean Time (6:00 A.M. ET) To access a live webcast of the presentation, visit Teva’s ...
TeraWulf Schedules Conference Call for Third Quarter 2025 Financial Results
Globenewswire· 2025-10-31 20:30
Core Viewpoint - TeraWulf Inc. is set to hold its earnings conference call for the third quarter of 2025 on November 10, 2025, at 4:30 p.m. ET, with a press release detailing the results to be issued prior to the call [1][2]. Group 1: Earnings Call Information - The earnings call will take place on November 10, 2025, at 4:30 p.m. ET [1]. - Participants can access the call via a dial-in number or a webcast link, with specific access details provided [4]. - A replay of the call will be available until November 24, 2025, with designated dial-in numbers for access [5]. Group 2: Company Overview - TeraWulf develops and operates environmentally sustainable, industrial-scale data center infrastructure in the U.S., focusing on high-performance computing (HPC) hosting and bitcoin mining [5]. - The company is led by experienced energy infrastructure entrepreneurs and aims to provide scalable, low-carbon compute capacity for next-generation AI and HPC customers [5].
Global Helium Corp. Announces Completion of Plan of Arrangement and Go-Private Transaction
Globenewswire· 2025-10-31 20:30
CALGARY, Alberta, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Global Helium Corp. ("Global" or the "Company") (CSE: HECO) and 2679158 Alberta Ltd. (the "Purchaser") announce today the closing of the previously announced acquisition of the Company by the Purchaser pursuant to a plan of arrangement under section 193 of the Business Corporations Act (Alberta) (the "Arrangement"). Pursuant to the Arrangement, the Purchaser acquired all of the issued and outstanding Class A Common Shares, Series A Preferred Shares and Ser ...
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-10-31 20:30
Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients  Preparing to submit Investigational New Drug applications for the treatment of psoriasis with CYPS317 and the treatment of multiple sclerosis with CYMS101 HOUSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issu ...
Global Helium Corp. Announces Completion of Plan of Arrangement and Go-Private Transaction
Globenewswire· 2025-10-31 20:30
CALGARY, Alberta, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Global Helium Corp. ("Global" or the "Company") (CSE: HECO) and 2679158 Alberta Ltd. (the "Purchaser") announce today the closing of the previously announced acquisition of the Company by the Purchaser pursuant to a plan of arrangement under section 193 of the Business Corporations Act (Alberta) (the "Arrangement"). Pursuant to the Arrangement, the Purchaser acquired all of the issued and outstanding Class A Common Shares, Series A Preferred Shares and Ser ...